Physician profile
John R Mackenzie
NPI 1326008764
$1,887.70
in general payments reported to CMS, 2019-2025
11 companies · $828 in 2025
The $828 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.06 · 2022: $71.51 · 2023: $299 · 2024: $614 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $470.37 | 2021-2025 | Wainua, Lokelma |
| Boston Scientific Corporation | $421.59 | 2023-2025 | Watchman Access System, Watchman, Watchman Flx |
| Abiomed | $318.99 | 2023-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $210.07 | 2024 | |
| Amgen INC. | $128.72 | 2021-2024 | Repatha |
| Actelion Pharmaceuticals US, INC. | $125.69 | 2024 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $89.87 | 2023-2025 | Eliquis, Camzyos |
| Pfizer INC. | $57.01 | 2021-2024 | |
| Medtronic, INC. | $35.88 | 2022 | |
| Chiesi USA, INC. | $15.46 | 2024 | Cleviprex, Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.05 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mackenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.